The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Transcriptional profiling of Tu212 cell line treated with EGCG and resveratrol to identify actionable targets for adjuvant therapy.
Dong Moon Shin
No relevant relationships to disclose
Bhakti Dwivedi
No relevant relationships to disclose
Ruhul A R M Amin
No relevant relationships to disclose
Abedul Md Haque
No relevant relationships to disclose
Nabil F. Saba
No relevant relationships to disclose
Michael R. Rossi
No relevant relationships to disclose
Zhuo Georgia Chen
No relevant relationships to disclose
Jeanne Kowalski
No relevant relationships to disclose